Browsing Barts Cancer Institute by Subject "Biomarker"
Now showing items 1-3 of 3
-
Insights Into the Pathophysiology of Esophageal Adenocarcinoma.
(2018-01)Although researchers have identified genetic alterations that contribute to development of esophageal adenocarcinoma, we know little about features of patients or environmental factors that mediate progression of chronic ... -
Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.
(Elsevier, 2020-11)BACKGROUND: Pre-clinical studies indicated that arginine-deprivation therapy using pegylated arginine deiminase (pegargiminase, ADI-PEG 20) may be effective in patients with argininosuccinate synthetase 1 (ASS1)-deficient ...